EUVIMEDEUVIMED entdecken
Crossref

Global and Regional Burden of Vaccine‐Associated Transverse Myelitis and Potentially Associated With Vaccines From 1967 to 2023: An Analysis of the International Pharmacovigilance Data

Jae E Lee, Hyesu Jo, Hanseul Cho, Jiyeon Oh, Yi Deun Jeong, Sooji Lee, Jaeyu Park, Hyeon Jin Kim, Yejun Son, Soeun Kim, Hayeon Lee, Louis Jacob und 4 weitere

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Jae E Lee und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Myelitis, Transverse, Pharmacovigilance, COVID-19 Vaccines, Vaccines. Die Arbeit nennt 42 Literaturangaben. Gefördert von: This study was supported by the MSIT (Ministry of Science and ICT), South Korea, under the ITRC (Information Technology Research Center) support program (IITP-….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Limited data on the potential safety risk of vaccine‐associated transverse myelitis (TM) is available. Thus, we aimed to identify the global burden and clinical features of vaccine‐associated TM to facilitate tailored monitoring of potential adverse vaccine reactions. This study used data from the World Health Organization pharmacovigilance database, which contains over 35 million reports from over 140 countries. We extracted individual case safety reports from 1967 to 2023. To investigate the potential association between 19 vaccines and TM, we calculated global reporting counts, reported odds ratios (ROR) with 95% confidence intervals (CI), and information components (IC) with IC 0.25 based on the Bayesian model. We identified 2305 reports (male, n = 999 [43.34%]) of vaccine‐associated TM from 4007 reports of all‐cause TM. Since the first report in 2010, the cumulative number of vaccine‐associated TM reports has steadily increased, with a significant increase after 2020 due to the emergence of COVID‐19 mRNA vaccines. Most vaccines were associated with TM (ROR, 42.62 [95% CI, 28.02–64.82]; IC, 4.46 [IC 0.25 , 3.75]), albeit with varying levels of signal. Typhoid vaccines had the highest signal with TM reports (ROR, 42.62 [28.02–64.82]; IC, 4.46 [3.75]), followed by hepatitis A (ROR, 38.04 [30.13–48.03]; IC, 4.90 [4.51]), influenza (ROR, 31.55 [28.17–35.32]; IC, 4.80 [4.62]), encephalitis, papillomavirus, and hepatitis B vaccines. Age‐ and sex‐specific analyses indicated that the risk of vaccine‐associated TM increased with age and to be more susceptible among males through ROR. The rate of fatal adverse outcomes of vaccine‐associated TM was 0.22%. This study highlights a potential signal detection between vaccines and the onset of TM, with vaccine‐associated reports comprising over half of all reported TM cases in the database. Although the incidence remains low, clinicians should remain vigilant for TM symptoms following vaccination, particularly in older adults where the risk appears to be higher. While our findings do not permit for causal inference, given the increasing trend of vaccine‐associated TM reports after 2020, continued pharmacovigilance and further research are needed to ensure timely detection and management of potential risks while maintaining the benefits of immunization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelitis, TransversePharmacovigilanceCOVID-19 VaccinesVaccinesHumansMaleFemaleMiddle AgedAdultAgedAdolescentYoung AdultChildChild, PreschoolInfantGlobal HealthWorld Health OrganizationDatabases, FactualCOVID-19

Stichwörter der Autor:innen

epidemiologyglobaltransverse myelitisvaccine

Substanzen

COVID-19 VaccinesVaccines

Autor:innen und Institutionen

  • Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea.
  • Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea.
  • Department of Regulatory Science, Kyung Hee University, Seoul, South Korea.
  • Department of Precision Medicine, Kyung Hee University, Seoul, South Korea.
  • Department of Electronics and Information Convergence Engineering, Kyung Hee University, Yongin, South Korea.
  • Department of Physical Medicine and Rehabilitation, Lariboisière-Fernand Widal Hospital, AP-HP, Université Paris Cité, Paris, France.

ORCID-Profile: Dong Keon Yon

Förderung

  • This study was supported by the MSIT (Ministry of Science and ICT), South Korea, under the ITRC (Information Technology Research Center) support program (IITP-…

Zitieren

APA

Lee, J. E., Jo, H., Cho, H., Oh, J., Jeong, Y. D., Lee, S., Park, J., Kim, H. J., Son, Y., Kim, S., Lee, H., Jacob, L., Pizzol, D., Woo, H. G., Hwang, J., & Yon, D. K. (2025). Global and Regional Burden of Vaccine‐Associated Transverse Myelitis and Potentially Associated With Vaccines From 1967 to 2023: An Analysis of the International Pharmacovigilance Data. Journal of Medical Virology. https://doi.org/10.1002/jmv.70408

Vancouver

Lee JE, Jo H, Cho H, Oh J, Jeong YD, Lee S, et al. Global and Regional Burden of Vaccine‐Associated Transverse Myelitis and Potentially Associated With Vaccines From 1967 to 2023: An Analysis of the International Pharmacovigilance Data. Journal of Medical Virology. 2025. doi:10.1002/jmv.70408

BibTeX
@article{Lee2025,
  author = {Lee, Jae E and Jo, Hyesu and Cho, Hanseul and Oh, Jiyeon and Jeong, Yi Deun and Lee, Sooji and Park, Jaeyu and Kim, Hyeon Jin and Son, Yejun and Kim, Soeun and Lee, Hayeon and Jacob, Louis and Pizzol, Damiano and Woo, Ho Geol and Hwang, Jiyoung and Yon, Dong Keon},
  title = {Global and Regional Burden of Vaccine‐Associated Transverse Myelitis and Potentially Associated With Vaccines From 1967 to 2023: An Analysis of the International Pharmacovigilance Data},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70408}
}
Kostenlos starten →